Russell Investments Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17K | Sell |
478
-24,180
| -98% | -$59.2K | ﹤0.01% | 3654 |
|
|
2025
Q1 | $164K | Sell |
24,658
-767,219
| -97% | -$5.12M | ﹤0.01% | 2644 |
|
|
2024
Q4 | $9.95M | Sell |
791,877
-20,433
| -3% | -$257K | 0.01% | 820 |
|
|
2024
Q3 | $15M | Buy |
812,310
+134,566
| +20% | +$2.49M | 0.02% | 683 |
|
|
2024
Q2 | $14.6M | Buy |
677,744
+1,975
| +0.3% | +$42.5K | 0.02% | 644 |
|
|
2024
Q1 | $18.2M | Buy |
675,769
+26,823
| +4% | +$723K | 0.03% | 584 |
|
|
2023
Q4 | $19.4M | Sell |
648,946
-79,463
| -11% | -$2.38M | 0.03% | 526 |
|
|
2023
Q3 | $14.9M | Buy |
728,409
+143,695
| +25% | +$2.94M | 0.03% | 578 |
|
|
2023
Q2 | $11.6M | Buy |
584,714
+79,192
| +16% | +$1.57M | 0.02% | 706 |
|
|
2023
Q1 | $8.66M | Buy |
505,522
+125,476
| +33% | +$2.15M | 0.02% | 836 |
|
|
2022
Q4 | $7.44M | Buy |
380,046
+199,945
| +111% | +$3.91M | 0.02% | 893 |
|
|
2022
Q3 | $2.87M | Buy |
180,101
+6,785
| +4% | +$108K | 0.01% | 1350 |
|
|
2022
Q2 | $2.38M | Buy |
+173,316
| New | +$2.38M | ﹤0.01% | 1500 |
|